Search - tctmd.com

Displaying 941 - 960 of 3000

Sort: Relevancy | Date

News Conference News ESC 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

Shelley Wood

August 31, 2021

News Conference News ESC 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

Todd Neale

August 29, 2021

News Conference News ESC 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Michael O'Riordan

August 28, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News

LVADs Can Be ‘Transformational’ for Elderly HF Patients

Caitlin E. Cox

August 25, 2021

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

News Daily News

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

Caitlin E. Cox

August 20, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

L.A. McKeown

August 16, 2021

News Daily News

MATRIX Score Predicts PCI Patients at High Risk for Transradial Failure

Michael O'Riordan

August 13, 2021

News Daily News

One in Six HF Patients Delay or Forego Care, Inflating Costs

Shelley Wood

August 12, 2021

News Daily News

Getting More Women in CV Research Will ‘Take a Village’

Yael L. Maxwell

August 09, 2021

News Industry News

Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic™ Endovascular System

August 04, 2021

News Daily News

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

Michael O'Riordan

July 27, 2021

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

Presentation TVT 2021

Assessment of Valvular Heart Disease Severity: Limitations and Opportunities for the Development of Advanced Analytical Algorithms

Presenter: João Cavalcante

July 21, 2021

News Industry News

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

July 21, 2021

Presentation TVT 2021

MASTER CLASS #1: Advanced Bioprosthetic Valve Failure Treated With TAVR

Presenter: John Webb

July 20, 2021

News Daily News

Apixaban May Be Best DOAC for Frail, Older Patients With AF

Todd Neale

July 19, 2021

News Industry News

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

July 14, 2021

Advertisement

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

LVADs Can Be ‘Transformational’ for Elderly HF Patients

Statins Positively Alter Coronary Plaque Composition

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

MATRIX Score Predicts PCI Patients at High Risk for Transradial Failure

One in Six HF Patients Delay or Forego Care, Inflating Costs

Getting More Women in CV Research Will ‘Take a Village’

Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic™ Endovascular System

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Assessment of Valvular Heart Disease Severity: Limitations and Opportunities for the Development of Advanced Analytical Algorithms

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

MASTER CLASS #1: Advanced Bioprosthetic Valve Failure Treated With TAVR

Apixaban May Be Best DOAC for Frail, Older Patients With AF

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content